Medicines
- Abraxane paclitaxel · Generic available Advanced non-small cell lung cancer (NSCLC)
- Taxotere docetaxel · Generic available Non-small cell lung cancer
- Iressa gefitinib · Generic available EGFR-mutated non-small cell lung cancer that has spread
- Alecensa alectinib · No generic yet ALK-positive non-small cell lung cancer (NSCLC)
- Alunbrig brigatinib · No generic yet ALK-positive non-small cell lung cancer that has spread
- Augtyro repotrectinib · No generic yet Advanced ROS1-positive non-small cell lung cancer
- Avastin bevacizumab · No generic yet Non-squamous non-small cell lung cancer
- Bizengri zenocutuzumab · No generic yet Advanced lung cancer (NSCLC) with an NRG1 gene fusion
- Braftovi encorafenib · No generic yet Non-small cell lung cancer that has spread, with a BRAF mutation
- Datroway datopotamab deruxtecan · No generic yet Advanced EGFR-mutated non-small cell lung cancer
- Docivyx docetaxel · No generic yet Lung cancer (non-small cell)
- Emrelis telisotuzumab vedotin · No generic yet Non-small cell lung cancer with high c-Met protein
- Enhertu fam-trastuzumab deruxtecan-nxki · No generic yet Non-small cell lung cancer with a HER2 mutation
- Ensacove ensartinib · No generic yet ALK-positive non-small cell lung cancer
- Gavreto pralsetinib · No generic yet Lung cancer (NSCLC) with a RET fusion that has spread
- Gilotrif afatinib · No generic yet Lung cancer (NSCLC) that has spread, with certain EGFR mutations; Squamous lung cancer (NSCLC) that has spread
- Hernexeos zongertinib · No generic yet Advanced lung cancer (NSCLC) with a HER2 mutation
- Hyrnuo sevabertinib · No generic yet Advanced lung cancer (NSCLC) with a HER2 mutation
- Ibtrozi taletrectinib · No generic yet Advanced ROS1-positive lung cancer (NSCLC)
- Imfinzi durvalumab · No generic yet
- Imjudo tremelimumab · No generic yet
- Jideytro zidesamtinib · No generic yet ROS1-positive non-small cell lung cancer
- Keytruda pembrolizumab · No generic yet Lung cancer (NSCLC) and mesothelioma
- Keytruda Qlex pembrolizumab and berahyaluronidase alfa-pmph · No generic yet Lung cancer (NSCLC) and mesothelioma
- Krazati adagrasib · No generic yet Lung cancer (NSCLC) with a KRAS G12C mutation
- Lazcluze lazertinib · No generic yet Lung cancer (NSCLC) with certain EGFR mutations
- Libtayo cemiplimab-rwlc · No generic yet
- Lorbrena lorlatinib · No generic yet ALK-positive non-small cell lung cancer (NSCLC)
- Lumakras sotorasib · No generic yet KRAS G12C-mutated non-small cell lung cancer
- Mekinist trametinib · No generic yet Non-small cell lung cancer with a BRAF mutation
- Mektovi binimetinib · No generic yet Non-small cell lung cancer with a BRAF mutation
- Mvasi bevacizumab-awwb · No generic yet Non-squamous non-small cell lung cancer
- Opdivo nivolumab · No generic yet Non-small cell lung cancer
- Opdivo Qvantig nivolumab and hyaluronidase-nvhy · No generic yet Non-small cell lung cancer
- Pemrydi Rtu pemetrexed disodium · No generic yet Non-small cell lung cancer (non-squamous)
- Retevmo selpercatinib · No generic yet Non-small cell lung cancer with a RET gene fusion
- Rozlytrek entrectinib · No generic yet ROS1-positive non-small cell lung cancer
- Rybrevant amivantamab-vmjw · No generic yet Non-small cell lung cancer with an EGFR mutation
- Rybrevant Faspro amivantamab and hyaluronidase-lpuj (human recombinant) · No generic yet Non-small cell lung cancer with an EGFR mutation
- Tabrecta capmatinib · No generic yet Non-small cell lung cancer with a MET gene change
- Tafinlar dabrafenib · No generic yet Non-small cell lung cancer with a BRAF gene change
- Tagrisso osimertinib · No generic yet Non-small cell lung cancer with an EGFR gene change
- Tecentriq atezolizumab · No generic yet
- Tecentriq Hybreza atezolizumab and hyaluronidase-tqjs · No generic yet
- Tepmetko tepotinib · No generic yet Non-small cell lung cancer with a MET gene change
- Vegzelma bevacizumab-adcd · No generic yet Non-squamous non-small cell lung cancer
- Vizimpro dacomitinib · No generic yet Non-small cell lung cancer (NSCLC) with an EGFR mutation
- Xalkori crizotinib · No generic yet ALK- or ROS1-positive non-small cell lung cancer that has spread
- Yervoy ipilimumab · No generic yet Non-small cell lung cancer
- Zirabev bevacizumab-bvzr · No generic yet Non-squamous non-small cell lung cancer
- Zykadia ceritinib · No generic yet ALK-positive non-small cell lung cancer that has spread
From each medicine’s FDA label. Only your prescriber can say which one is right for you, and many are prescribed for other reasons too.